SCHEMBL9332276

SCHEMBL9332276

CCC(C(=O)Oc1ccc([S+](C)[O-])cc1)c1ccsc1

nearest known ligand 0.35

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
ESR1 P03372 1/20 0.33
HIF1A Q16665 1/20 0.33
CYP19A1 P11511 1/20 0.32
ALOX5 P09917 1/20 0.32
AKR1C3 P42330 3/20 0.30
AKR1C2 P52895 3/20 0.30
AKR1C1 Q04828 1/20 0.30
PTGS1 P23219 1/20 0.30
ELANE P08246 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7353801 0.81 AKR1C3 (0.43) ESR1HIF1ACYP19A1AKR1C3AKR1C2
SCHEMBL11362145 0.74 CHRNB2 (0.43) CHRNB2CHRNB4CHRNA3CHRNA4ALOX5
SCHEMBL10683115 0.74 CHRNB2 (0.43) CHRNB2CHRNB4CHRNA3CHRNA4ESR1
SCHEMBL7387231 0.72 NPC1 (0.32) ESR1HIF1AELANE
SCHEMBL600267 0.69 AKR1C3 (0.44) CHRNB2CHRNB4CHRNA3CHRNA4ALOX5
SCHEMBL7386582 0.68 L3MBTL1 (0.38) CHRNB2CHRNB4CHRNA3CHRNA4ALOX5
SCHEMBL14941251 0.67 ESR1 (0.49) ESR1HIF1ACYP19A1AKR1C3AKR1C2
SCHEMBL11210301 0.67 LMNA (0.48) ESR1HIF1ACYP19A1AKR1C3AKR1C2
SCHEMBL4488140 0.67 AKR1C3 (0.45) AKR1C3AKR1C2AKR1C1PTGS1
SCHEMBL7347806 0.66 MEN1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5314910-A 2-Heteroaromatic alkanoate esters useful as inhibitors of human leukocyte or neutrophil elastase CORTECH INC. (US) 1994-05-24 US disclosed
US-5240956-A Phenyl 2-heteroaromatic-alkanoates, elastase inhibitors CORTECH, INC. (US) 1993-08-31 US disclosed